Identification of molecular signatures for the prognostic study of patients with signs of severe acute respiratory syndrome caused by the new coronavirus (SARS CoV2)
- Funded by FAPEAM Brazil
- Total publications:0 publications
Grant number: unknown
Grant search
Key facts
Disease
COVID-19start year
-99Known Financial Commitments (USD)
$50,757.24Funder
FAPEAM BrazilPrincipal Investigator
Wuelton Marcelo MonteiroResearch Location
BrazilLead Research Institution
FMT-HVDResearch Priority Alignment
N/A
Research Category
Clinical characterisation and management
Research Subcategory
Prognostic factors for disease severity
Special Interest Tags
N/A
Study Type
Unspecified
Clinical Trial Details
N/A
Broad Policy Alignment
Pending
Age Group
Unspecified
Vulnerable Population
Unspecified
Occupations of Interest
Unspecified